English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

The D antigen is highly immunogenic and may cause alloimmunization to occur after blood transfusion or pregnancy. Some  RHD  variant alleles express a D antigen that is missing one or more epitopes, thus putting a presumed D+ patient at risk for alloanti-D and hemolytic disease of the fetus and newborn. It is generally accepted that individuals who have a serologic weak D phenotype due to one of three alleles common in Caucasians,  RHD*weak D types 1, 2,  or  3,  are not at risk for alloimmunization. In this study, blood samples from 46 obstetrics patients from a local health system were identified based on discrepant results between automated gel and manual tube testing  (n  = 20) or based on presentation with a serologic weak D phenotype ( n  = 26).  RHD  genotyping was performed using commercial and laboratory-developed tests. Of the 26 serologic weak D samples, 18 (69.2%) were found to carry alleles  RHD*weak D type 1, 2 , or  3 . The remaining eight samples (30.8%) were found to carry partial D alleles. Of the 20 samples submitted because of D typing discrepancy, 7 (35%) carried alleles  RHD*weak D type 1, 2,  or  3 , while 13 (65%) carried partial  RHD  alleles. This report summarizes the findings of one hospital system and its approach to integrating  RHD  genotyping into its assessment of risk of alloimmunization in obstetrics patients. It demonstrates that individuals with partial  RHD  alleles can present with serologic weak D phenotype, such that, without  RHD  genotyping, these individuals may not be identified as candidates for Rh immune globulin. The study also demonstrates that use of two methods (automated gel and tube testing) allows for identification of partial D cases that would otherwise be missed.  Immunohematology  2020;36:146-151.

Identifying obstetrics patients in whom RHD genotyping can be used to assess risk of D alloimmunization